FDA Debuts List For Rapidly Announcing Noncompliant Ingredients In Supplements
Executive Summary
FDA announces addition of Dietary Supplement Ingredient Advisory List page to its website to identify ingredients it has preliminary determined should be used in dietary supplements. It also publishes warning letters submitted recently to firms marketing supplements containing two ingredients agency has concluded should not be used: eight were warned about using an ingredient identified as "DMHA" and three about using phenibut.
You may also be interested in...
FDA's Latest Hornedine Find Is On Texas Firm’s Supplement Labels During Website Inspection
Hornedine isn’t an “old” dietary ingredient exempt from pre-market notification with proof its safety because it wasn’t available in the US food supply before October 1994. "T
US Supplement Firm Warned About Phenibut After Failing To Pull PTSD, Detox, Anxiety Claims
Latest FDA warning to Chill6 doesn’t reference previous letter but lists larger number of violations along with more details about the problems. Agency also recently added salt scrub therapies to its list of products as marketed with fraudulent coronavirus treatment claims.
Another Notice For Comments On Kratom: Cue Second Wave Of Support For Botanical In US?
FDA states in Federal Register notice that WHO has requested information on whether kratom – mitragynine, 7-hydroxymitragynine – should be added to the United Nations’ schedule of controlled substances.